ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $150,000 | -0.7% | 150,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $151,000 | -1.3% | 150,000 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $153,000 | -6.1% | 150,000 | 0.0% | 0.01% | -10.0% |
| Q4 2020 | $163,000 | +4.5% | 150,000 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $156,000 | -6.0% | 150,000 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $166,000 | +8.5% | 150,000 | 0.0% | 0.01% | -44.0% |
| Q1 2020 | $153,000 | -98.8% | 150,000 | -98.6% | 0.02% | -99.2% |
| Q3 2019 | $12,253,000 | -3.8% | 10,734,000 | 0.0% | 3.09% | -6.9% |
| Q2 2019 | $12,733,000 | -12.3% | 10,734,000 | 0.0% | 3.32% | -22.2% |
| Q1 2019 | $14,515,000 | +308.2% | 10,734,000 | +114.7% | 4.27% | +1356.0% |
| Q2 2016 | $3,556,000 | -22.1% | 5,000,000 | 0.0% | 0.29% | -19.9% |
| Q1 2016 | $4,564,000 | – | 5,000,000 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alken Asset Management Ltd | 850,000 | $848,000 | 3.53% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 34,448,000 | $35,346,000 | 1.72% |
| Sonora Investment Management, LLC | 9,376,000 | $9,408,000 | 1.12% |
| CSS LLC/IL | 7,500,000 | $7,639,000 | 0.60% |
| IRON Financial LLC | 490,000 | $498,000 | 0.31% |
| MACKAY SHIELDS LLC | 32,910,000 | $33,383,000 | 0.31% |
| RWC Asset Management LLP | 4,550,000 | $4,642,000 | 0.24% |
| Opti Capital Management, LP | 1,000 | $1,024,000 | 0.21% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $4,956,000 | 0.18% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,283,000 | $5,301,000 | 0.12% |